Insider Buying: OneMedNet (NASDAQ:ONMD) CEO Acquires 36,920 Shares of Stock

Posted by Geri Gentry on Jun 16th, 2026

OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) CEO Aaron Green bought 36,920 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was bought at an average cost of $0.56 per share, with a total value of $20,675.20. Following the transaction, the chief executive officer directly owned 1,841,023 shares in the company, valued at approximately $1,030,972.88. The trade was a 2.05% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Aaron Green also recently made the following trade(s):

On Monday, June 15th, Aaron Green bought 18,702 shares of OneMedNet stock. The stock was bought at an average cost of $0.54 per share, with a total value of $10,099.08.

OneMedNet Stock Performance

ONMD opened at $0.56 on Tuesday. The company has a 50-day moving average of $0.87 and a 200-day moving average of $0.96. The company has a market capitalization of $30.37 million, a P/E ratio of -11.16 and a beta of 1.12. OneMedNet Corporation has a 1-year low of $0.31 and a 1-year high of $4.22.

OneMedNet (NASDAQ:ONMD – Get Free Report) last released its earnings results on Friday, May 15th. The company reported ($0.04) earnings per share for the quarter. The firm had revenue of $0.10 million for the quarter.

Institutional Investors Weigh In On OneMedNet

Institutional investors have recently modified their holdings of the business. HRT Financial LP bought a new stake in shares of OneMedNet during the 4th quarter valued at about $32,000. Virtu Financial LLC bought a new stake in shares of OneMedNet during the 4th quarter valued at about $48,000. Jane Street Group LLC bought a new stake in shares of OneMedNet during the 4th quarter valued at about $119,000. State Street Corp grew its position in shares of OneMedNet by 41.5% during the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after buying an additional 34,200 shares during the last quarter. Finally, Exencial Wealth Advisors LLC grew its position in shares of OneMedNet by 1.3% during the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after buying an additional 45,401 shares during the last quarter. Institutional investors own 0.95% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on ONMD shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen downgraded shares of OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

View Our Latest Stock Report on ONMD

About OneMedNet

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.